Stability of N-glycan profiles in human plasma
Open Access
- 2 September 2009
- journal article
- Published by Oxford University Press (OUP) in Glycobiology
- Vol. 19 (12), 1547-1553
- https://doi.org/10.1093/glycob/cwp134
Abstract
Glycan heterogeneity was shown to be associated with numerous diseases and glycan analysis has a great diagnostic potential. Recently, we reported high biological variability of human plasma N-glycome at the level of population. The observed variations were larger than changes reported to be associated with some diseases; thus, it was of great importance to examine the temporal constancy of human N-glycome before glycosylation changes could be routinely analyzed in diagnostic laboratories. Plasma samples were taken from 12 healthy individuals. The blood was drawn on seven occasions during 5 days. N-Linked glycans, released from plasma proteins, were separated using hydrophilic interaction high-performance liquid chromatography into 16 groups (GP1-GP16) and quantified. The results showed very small variation in all glycan groups, indicating very good temporal stability of N-glycome in a single individual. Coefficients of variation from 1.6% for GP8 to 11.4% for GP1 were observed. The average coefficient of variation was 5.6%. These variations were comparable to those observed when analytical procedure was tested for its precision. Good stability of plasma N-glycome in healthy individuals implies that glycosylation is under significant genetic control. Changes observed in glycan profiles are consequence of environmental influences and physiologic responses and therefore have a significant diagnostic potential.Keywords
This publication has 28 references indexed in Scilit:
- Variability, Heritability and Environmental Determinants of Human Plasma N-GlycomeJournal of Proteome Research, 2008
- Regulated Glycosylation Patterns of IgG during Alloimmune Responses against Human Platelet AntigensJournal of Proteome Research, 2008
- Outer arm fucosylation of N-glycans increases in sera of hepatocellular carcinoma patientsBiochemical and Biophysical Research Communications, 2008
- Biological Function of Fucosylation in Cancer BiologyThe Journal of Biochemistry, 2007
- Management of severe acute pancreatitis: itʼs all about timingCurrent Opinion in Critical Care, 2007
- Glycosylation of site-specific glycans of α1-acid glycoprotein and alterations in acute and chronic inflammationBiochimica et Biophysica Acta (BBA) - General Subjects, 2005
- Increased sialylation and defucosylation of plasma proteins are early events in the acute phase responseGlycobiology, 2005
- α1‐Acid glycoprotein fucosylation as a marker of carcinoma progression and prognosisCancer, 2004
- A preliminary evaluation of the differences in the glycosylation of alpha-1-acid glycoprotein between individual liver diseasesBiomedical Chromatography, 2002
- Glycosylation ofα 1 glycoprotein in septic shock: Changes in degree of branching and in expression of sialyl Lewisx groupsGlycoconjugate Journal, 1996